CVR: 45618706
Secondary names: Efflux Pharma ApS
Selskabet af 9. maj 2025 ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Nils Aage Brünner. The company is owned by Resistance Oncology ApS.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at forske, udvikle, producere og sælge lægemidler og lægemiddelkandidater samt relaterede teknologier.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAs of June 23, 2025, Nils Aage Brünner is registered as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of June 23, 2025, Kasper Pasternak Jørgensen has stepped down as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, Kasper Pasternak Jørgensen is registered as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, Resistance Oncology ApS is registered as an owner of Selskabet af 9. maj 2025 ApS with an ownership share of 100%.
Selskabet af 9. maj 2025 ApS was founded on May 15, 2025.
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 29418888
CVR 29769796
CVR 34892970
companydata.dk